Twist Bioscience Corp (TWST)
41.21
+9.20
(+28.74%)
USD |
NASDAQ |
May 03, 16:00
41.18
-0.03
(-0.07%)
After-Hours: 20:00
Twist Bioscience Cash from Operations (Quarterly): -19.42M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -19.42M |
| December 31, 2023 | -22.97M |
| September 30, 2023 | -20.70M |
| June 30, 2023 | -23.41M |
| March 31, 2023 | -44.29M |
| December 31, 2022 | -54.07M |
| September 30, 2022 | -1.267M |
| June 30, 2022 | -34.12M |
| March 31, 2022 | -42.34M |
| December 31, 2021 | -46.65M |
| September 30, 2021 | -34.80M |
| June 30, 2021 | -27.96M |
| March 31, 2021 | -24.55M |
| Date | Value |
|---|---|
| December 31, 2020 | -24.93M |
| September 30, 2020 | -25.20M |
| June 30, 2020 | -23.47M |
| March 31, 2020 | -58.67M |
| December 31, 2019 | -34.91M |
| September 30, 2019 | -23.36M |
| June 30, 2019 | -22.08M |
| March 31, 2019 | -20.81M |
| December 31, 2018 | -21.68M |
| September 30, 2018 | -16.70M |
| June 30, 2018 | -16.94M |
| March 31, 2018 | -16.51M |
| December 31, 2017 | -16.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-58.67M
Minimum
Mar 2020
-1.267M
Maximum
Sep 2022
-30.46M
Average
-25.07M
Median
Cash from Operations (Quarterly) Benchmarks
| Tandem Diabetes Care Inc | -7.216M |
| Perspective Therapeutics Inc | -9.008M |
| Xtant Medical Holdings Inc | -0.915M |
| Asensus Surgical Inc | -13.37M |
| Catheter Precision Inc | -1.889M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -5.24M |
| Cash from Financing (Quarterly) | 1.828M |
| Free Cash Flow | -95.52M |
| Free Cash Flow Per Share (Quarterly) | -0.3466 |
| Free Cash Flow to Equity (Quarterly) | -20.03M |
| Free Cash Flow to Firm (Quarterly) | -20.03M |
| Free Cash Flow Yield | -4.04% |